Ads
related to: therapeutics
Search results
Dyne Therapeutics launches $300 million stock offering By Investing.com
Investing.com· 7 days agoDyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company specializing in muscle disease...
AKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC...
FOX 23 News Albany· 2 days agoFoti, Jr., remind investors that they have until June 25, 2024 to file lead plaintiff applications...
Where Will Viking Therapeutics Be in 5 Years?
Motley Fool via Yahoo Finance· 2 days agoIf you're looking at up-and-coming healthcare stocks with significant potential in the anti-obesity market, one company you've likely come across is...
Assetmark Inc. Increases Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
ETF DAILY NEWS· 1 day agoAssetmark Inc. boosted its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 221.9% in the 4th quarter, according to the company in its most ...
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
KTLA-TV Los Angeles· 3 days agoShanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies ...
IRLAB Appoints Kristina Torfgård as New CEO
StreetInsider· 1 hour agoIRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) - a company discovering and developing novel treatments for Parkinson's disease - announces today that its Board of Directors ...
Beam Therapeutics (NASDAQ:BEAM) Stock Price Down 4.7%
ETF DAILY NEWS· 2 days agoBeam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report)’s stock price fell 4.7% during mid-day trading on Thursday . 124,474 shares traded hands during mid-day trading, a decline ...
Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M
Zacks via Yahoo Finance· 3 days agoBicycle Therapeutics (BCYC) gains 10% upon entering a PIPE financing agreement with multiple...
When Will Vivoryon Therapeutics N.V. (AMS:VVY) Become Profitable?
Simply Wall St. via Yahoo Finance· 5 days agoVivoryon Therapeutics N.V. (AMS:VVY) is possibly approaching a major achievement in its business, so...
Entero Therapeutics, Inc. (NASDAQ:ENTO) to Post Q2 2024 Earnings of ($1.55) Per Share, Roth Capital...
ETF DAILY NEWS· 3 days agoEntero Therapeutics, Inc. (NASDAQ:ENTO – Free Report) – Roth Capital issued their Q2 2024 earnings...